Tag Archive for: cancer care delivery research

Cancer Care Delivery Research

Cancer Care Delivery Research (CCDR) is a multidisciplinary science that seeks to improve clinical outcomes and patient well-being by intervening on patient, clinician, and organizational factors that influence care delivery.

CCDR generates evidence that can be used to improve clinical practice patterns as well as develop and test promising interventions within the health care delivery system. It also supports development of new and generalizable knowledge about the effectiveness, acceptability, cost, optimal delivery mode, and causal mechanisms that influence outcomes and affect the value of cancer care across diverse settings and populations. The goal of CCDR is evidence-based practice transformation.

Integrating CCDR within NCORP provides the ability to collect primary data on current delivery practices and initiate interventions in non-academic settings; look across a mix of practice models and heterogeneous populations; and follow patients from time of diagnosis through treatment and survivorship.

In this video, Philip J. Stella, M.D., principal investigator of the Michigan Cancer Research Consortium NCI Community Oncology Research Program (NCORP) describes how cancer care delivery research works to find the best way to care for patients.

Source: www.ncorp.cancer.gov

Cancer Care Delivery Research (CCDR) and NCORP

NCORP is committed to providing superior care and clinical research to patients in their communities.  Cancer Care Delivery Research (CCDR) is a multidisciplinary science that seeks to improve clinical outcomes and patient well-being by intervening on patient, clinician, and organizational factors that influence care delivery.

The NCI Community Oncology Research Program (NCORP)External Web Site Policy offers unique opportunities to conduct care delivery research in community settings where the majority of cancer patients receive their treatment. Integrating care delivery research within the NCORP network provides the ability to collect primary data and initiate interventions; look across a mix of practice models and heterogeneous populations; and follow patients from time of diagnosis through treatment and survivorship.

(From www.cancer.gov)